"eye clinics were unable to keep pace with demand.... In four out of five cases, those affected had chronic conditions requiring long term follow up, meaning they are not covered by NHS targets." https://www.telegraph.co.uk/news/2018/06/06/hundreds-going-b...
While pathetic, it's not clear how it follows, as the DW asserts, "This is what will happen in America if Democrats get their way on 'Medicare for all.'" There are lots of countries with socialized medicine without the problem that NHS has. DW fails to mention that, possibly because of its bias. Private insurers in the US, in the meantime, are widely known to pick-and-choose what they will cover ... and will not.
Edit: here's a description of 'Medicare for All' from Forbes. https://www.forbes.com/sites/teresaghilarducci/2018/07/16/wh...
The US is already paying far more for healthcare than the UK, and that stays true even if we only consider government funding and ignore insurance. There's no reason something similar would happen in the US.
Also, that report mentions macular degeneration, and this is a problem mostly caused by terrible pharma practices.
Avastin and lucentis are very similar. Avastin is older, and is much cheaper than lucentis. They can both be used to treat AMD. The owner has licenced lucentis for use in AMD, and has chosen not to licence avantis for AMD. This means that doctors can use avastin "off label". The rights-holders decided to sue the NHS to prevent this off-label use.
https://www.bbc.co.uk/news/health-30138097
https://www.hsj.co.uk/finance-and-efficiency/breaking-nhs-wi...